BASE Facility, within the Australian Institute for Bioengineering and Nanotechnology (AIBN). Full-time (100%), fixed-term position through August 2027. Base salary will be in the range $97,269 to $104,349 + 17% super (HEW Level 6). Based at
Company Nurix Therapeutics is a clinical stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted protein degradation medicines, the next frontier in innovative drug design aimed at improving treatment options for patients with